-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Undervalued Tilray Stock Is a Hidden Cannabis Gem in Plain Sight
As Tilray works slowly but surely toward profitability, enterprising investors can start a position in TLRY stock while it's super cheap.
Teladoc (TDOC) Stock Slides After Announcing Operational Review
Teledoc is making progress against its operating losses, but investors who bought TDOC stock for pandemic growth are leaving.
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.
Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today?
InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results.
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
Sonnet BioTherapeutics stock is dropping on Wednesday after the company revealed the pricing of a public offering for SONN shares.
Why Is Reshape Lifesciences (RSLS) Stock Up 59% Today?
Reshape Lifesciences stock is heading higher on Wednesday with heavy trading of RSLS shares despite a lack of news from the company.
Why Is InMed (INM) Stock Up 110% Today?
Here's what investors in INM stock may want to watch, given the company's recent impressive early results from an Alzheimer's drug candidate.
Why Is LianBio (LIAN) Stock Up 130% Today?
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.
Why Is LumiraDx (LMDX) Stock Down 35% Today?
LumiraDx stock is falling on Tuesday as shares of LMDX stock give up some of the gains they saw on Monday after announcing a partnership.
Why Is INVO Bioscience (INVO) Stock Up 325% Today?
Here's what investors in INVO Bioscience may want to know, as INVO stock absolutely skyrockets more than 325% in today's session.
Why Is Roivant Sciences (ROIV) Stock Up Today?
With its deal for RVT-3101, Roivant proved its model of finding stalled drugs and getting them the cash they need to reach the market.
Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?
XRTX stock is falling on Monday as the pharmaceutical company's shares retreat from a massive rally on Friday.
Why Is Akumin (AKU) Stock Up 51% Today?
Akumin stock is on the rise Monday after announcing a deal with investment firm Stonepeak that will take the company private!